Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk
Status:
Not yet recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
Infections are common and associated with poor outcomes as well as high financial costs after
kidney transplantation. Identifying and implementing strategies to reduce infections after
kidney transplantation is important for improving patient outcomes. This study seeks to
determine the feasibility of body surface area-based dosing of mycophenolate compared to
standard dosing of mycophenolate in a pilot randomized controlled trial.